BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 17, 2021
View Archived Issues
Osmol initiates IND-enabling studies of OSM-0205 for prevention of CIPN
Read More
Regeneron's REGN-7483F Mini-VEGF-Trap could be a next-generation VEGF inhibitor
Read More
Phase II/III XIRIUS study of cotoretigene toliparvovec in XLPR does not meet primary endpoint
Read More
SK Biopharmaceuticals divulges PRMT5 inhibitors
Read More
Gilead Sciences patents GLP-1R agonists
Read More
Kinnate Biopharma synthesizes new Raf kinase C inhibitors
Read More
ARKUDA Therapeutics identifies PGRN modulators
Read More
Shire Human Genetic Therapies describes new AAV-based gene therapy for HAE
Read More
CureVac reports promising preclinical data for its second-generation COVID-19 vaccine candidate
Read More
Combined administration of BNT-152 and BNT-153 results in synergistic antitumor effects
Read More
FDA approves Empaveli for PNH
Read More
Clinical results of an individualized multimodal immunotherapy
Read More
Phase II data on Sanofi and GSK COVID-19 vaccine candidate show favorable immune responses
Read More
Memo's MTX-COVAB shows efficacy against original SARS-CoV-2 and U.K. variant
Read More
Phase I results presented for rAAV9.U7snRNA.ACCA in DMD
Read More
Seelos reports open-label data on SLS-002 for acute suicidal ideation and behavior in MDD
Read More
New murine model of myotonic dystrophy 1 developed
Read More
Rise Biopharmaceuticals initiates phase I study of RP-72 in pancreatic cancer
Read More
Australian researchers map out first genetic profile of skeletal master regulator cells
Read More
Galera begins dosing in phase IIb study of GC-4711 in pancreatic cancer
Read More
Phase III trials of ruxolitinib in vitiligo meet endpoints
Read More